CGS International, October 13, 2025 Excerpt from CGS International report. Report Summary: China and the US have escalated trade tensions ahead of a key leaders’ meeting, with China imposing new export controls on rare...

CGS International August 5, 2025 LHN Ltd Signals Bullish Continuation Amid Shifting Global Economic Landscape Overview of Economic Backdrop and Market Sentiment The latest research from CGS International highlights the current state of the...

Company Highlights: Innovent Biologics is evolving from a biotech company to a major pharmaceutical player in China, driven by its diverse drug pipeline. Key drugs such as Sintilimab, the company’s leading anti-PD-1 antibody, and...